MAIA MAIA Biotechnology, Inc.
Price Chart
Executive Summary
MAIA Biotechnology closed an underwritten public offering of 20 million shares at $1.50 per share, raising $30 million in gross proceeds. The company may raise an additional $4.5 million if underwriters exercise their 30-day option to purchase 3 million more shares. Proceeds will fund clinical trials and general corporate purposes.
Key Financial Metrics
Actionable Insight
Monitor for potential share price pressure due to near-term dilution; assess whether the capital raise extends the company's runway meaningfully into key clinical milestones.
Key Facts
- MAIA raised $30 million in gross proceeds through the sale of 20 million shares at $1.50 per share.
- Underwriters have a 30-day option to purchase up to an additional 3 million shares.
- Financing included participation from healthcare-dedicated investors and existing shareholders.
- Net proceeds will be used for clinical trials, working capital, and general corporate purposes.
- Offering was conducted under a shelf registration (Form S-3) declared effective in August 2023.
Financial Impact
$30 million gross proceeds, with potential for $4.5 million more; significant dilution expected due to large share issuance
Risk Factors
- Significant equity dilution for existing shareholders given the large number of new shares issued.
- No guarantee that clinical programs will advance successfully despite additional funding.
Market Snapshot
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3249706 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 3, 2026
6d ago
|
Press Release
| $1.43 $1.50 | ▲ +4.90% | ▲ +4.50% | $1.27 (−11.19%) |
|
Jun 2, 2026
7d ago
|
Insider Cluster
| $1.35 $1.43 | ▲ +5.93% | ▲ +6.62% | $1.27 (−5.93%) |
|
May 19, 2026
21d ago
|
DEFA14A
| $1.23 $1.29 | ▲ +4.88% | ▲ +3.84% | $1.27 (+3.25%) |
|
May 14, 2026
26d ago
|
8-K
| $1.26 $1.26 | · 0.00% | ▲ +0.06% | $1.27 (+0.79%) |
|
Apr 27, 2026
6w ago
|
DEFA14A
| $1.24 $1.25 | ▲ +0.81% | ▲ +1.29% | $1.27 (+2.42%) |
|
Apr 16, 2026
7w ago
|
8-K
| $1.33 $1.35 | ▲ +1.50% | ▲ +0.29% | $1.27 (−4.51%) |
|
Apr 8, 2026
8w ago
|
8-K
| $1.24 $1.20 | ▼ −3.23% | ▼ −3.80% | $1.27 (+2.42%) |
|
Apr 7, 2026
9w ago
|
DEFA14A
| $1.20 $1.24 | ▲ +3.33% | ▲ +0.79% | $1.27 (+5.83%) |
|
Mar 4, 2026
13w ago
|
Press Release
| $1.53 $1.54 | ▲ +0.65% | ▲ +1.97% | $1.27 (−16.99%) |
|
Mar 3, 2026
14w ago
|
Press Release
| $1.51 $1.56 | ▼ −3.31% | ▼ −2.55% | $1.27 (+15.89%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access